Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC
FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC
150.12BUSD
Jenis
Common Stock
Menukarkan
NYSE
Kode mata uang
USD
Nama Mata Uang
US Dollar
Nama negara
USA
ISO Negara
US
ADALAH
US7170811035
CUSIP
717081103
Sektor
Healthcare
Industri
Drug Manufacturers - General
Akhir Tahun Anggaran
December
tanggal IPO
-
Diperbarui Pada
-
Rasio PE
35.07
Rasio PEG
0.20
Nilai buku
16.29
Pembagian Dividen
1.67
Hasil Dividen
6.54%
Bagi Hasil
0.75
Target Harga Wall Street
31.175
Estimasi EPS Tahun Ini
2.9271
Estimasi EPS Tahun Depan
2.9256
Perkiraan EPS Kuartal Saat Ini
0.62
Estimasi EPS Kuartal Berikutnya
0.66
Kuartal Terbaru
-
Pendapatan TTM
59,375,001,600
TTM Laba Kotor
41,430,999,040
EBITDA
18,365,999,104
Margin Keuntungan
7.16%
Pengembalian Aset TTM
3.31%
Pengembalian Ekuitas TTM
4.54%
Pendapatan Per Saham TTM
10.493
Pertumbuhan Pendapatan Kuartalan YOY
31.20%
Eps TTM yang diencerkan
0.75
Pertumbuhan Pendapatan Kuartalan YOY
-98.20%
tertinggal PE
35.07
Maju PE
8
Harga Jual TTM
2.5102
Buku Harga MRQ
1.615
Pendapatan Nilai Perusahaan
3
EBITDA Nilai Perusahaan
14
321.00
3.68%134.98
2.16%78.60
-4.67%728.05
-3.96%98.10
-2.60%288.70
-2.06%171.85
-1.08%36.35
-0.87%66.50
-0.61%147.30
-0.32%